161 related articles for article (PubMed ID: 9362347)
1. Human hepatocyte growth factor in bile: an indicator of posthepatectomy liver function in patients with biliary tract carcinoma.
Takeuchi E; Nimura Y; Nagino M; Kurumiya Y; Maeda A; Kamiya J; Kondo S; Kanai M; Miyachi M; Uesaka K; Yoshida S
Hepatology; 1997 Nov; 26(5):1092-9. PubMed ID: 9362347
[TBL] [Abstract][Full Text] [Related]
2. Biliary bile acid concentration is a simple and reliable indicator for liver function after hepatobiliary resection for biliary cancer.
Kurumiya Y; Nagino M; Nozawa K; Kamiya J; Uesaka K; Sano T; Yoshida S; Nimura Y
Surgery; 2003 May; 133(5):512-20. PubMed ID: 12773979
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 6 in bile as an indicator of liver function after hepatectomy in patients with biliary tract carcinoma.
Maeda A; Nagino M; Takeuchi E; Sano T; Kurumiya Y; Nimura Y
Br J Surg; 1999 Apr; 86(4):458-64. PubMed ID: 10215814
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor concentration in rat bile is affected by hepatic resection volume and external biliary drainage.
Hayata A; Takeuchi E; Nagino M; Yoshida S; Nimura Y
J Surg Res; 1999 Jul; 85(1):71-6. PubMed ID: 10383840
[TBL] [Abstract][Full Text] [Related]
5. Serum interleukin-6 and hepatocyte growth factor levels in patients after hepatectomy.
Chijiiwa K; Saiki S; Tanaka M
Hepatogastroenterology; 2002; 49(44):467-71. PubMed ID: 11995475
[TBL] [Abstract][Full Text] [Related]
6. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats.
Appasamy R; Tanabe M; Murase N; Zarnegar R; Venkataramanan R; Van Thiel DH; Michalopoulos GK
Lab Invest; 1993 Mar; 68(3):270-6. PubMed ID: 8450646
[TBL] [Abstract][Full Text] [Related]
8. Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma.
Hu RH; Lee PH; Yu SC; Sheu JC; Lai MY
Hepatogastroenterology; 1999; 46(27):1842-7. PubMed ID: 10430357
[TBL] [Abstract][Full Text] [Related]
9. Serum transforming growth factor-alpha level can be a parameter for evaluating liver regeneration after partial hepatectomy in patients with liver cancer.
Tomiya T; Hayashi S; Yanase M; Umeda N; Tani M; Yamada S; Masaki N; Ogata I; Fujiwara K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-14-S6-17. PubMed ID: 9151911
[TBL] [Abstract][Full Text] [Related]
10. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
[TBL] [Abstract][Full Text] [Related]
11. The role of a protease inhibitor against hepatectomy.
Gotohda N; Iwagaki H; Ozaki M; Konishi M; Nakagohri T; Takahashi S; Yagi T; Kinoshita T; Tanaka N
Hepatogastroenterology; 2006; 53(67):115-9. PubMed ID: 16506388
[TBL] [Abstract][Full Text] [Related]
12. Changes in serum levels of growth factors in healthy individuals after living related liver donation.
Efimova EA; Glanemann M; Nussler AK; Schumacher G; Settmacher U; Jonas S; Nussler N; Neuhaus P
Transplant Proc; 2005 Mar; 37(2):1074-5. PubMed ID: 15848626
[TBL] [Abstract][Full Text] [Related]
13. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
Chau GY; Lui WY; Chi CW; Chau YP; Li AF; Kao HL; Wu CW
Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078
[TBL] [Abstract][Full Text] [Related]
14. Serum hepatocyte growth factor levels in liver diseases: clinical implications.
Shiota G; Okano J; Kawasaki H; Kawamoto T; Nakamura T
Hepatology; 1995 Jan; 21(1):106-12. PubMed ID: 7806142
[TBL] [Abstract][Full Text] [Related]
15. Liver functional analysis by total bile acid level of C-tube bile after hepatectomy.
Hotta T; Kobayashi Y; Taniguchi K; Johata K; Sahara M; Ochiai M; Watanabe T; Tanimura H
Hepatogastroenterology; 2005; 52(64):1211-5. PubMed ID: 16001663
[TBL] [Abstract][Full Text] [Related]
16. Portal serum human hepatocyte growth factor levels after partial hepatectomy.
Higaki I; Yamazaki O; Matsuyama M; Horii K; Kawai S; Hirohashi K; Kinoshita H
Hepatogastroenterology; 1999; 46(26):1078-82. PubMed ID: 10370670
[TBL] [Abstract][Full Text] [Related]
17. Profile of hepatocyte growth factor in patients with obstructive jaundice.
Hu RH; Lee PH; Yu SC; Ho MC
Hepatogastroenterology; 2003; 50(54):1987-90. PubMed ID: 14696449
[TBL] [Abstract][Full Text] [Related]
18. Effects of human hepatocyte growth factor on the proliferation of human hepatocytes and hepatocellular carcinoma cell lines.
Efimova EA; Glanemann M; Liu L; Schumacher G; Settmacher U; Jonas S; Langrehr JM; Neuhaus P; Nüssler AK
Eur Surg Res; 2004; 36(5):300-7. PubMed ID: 15359093
[TBL] [Abstract][Full Text] [Related]
19. Significant correlation between surgical stress of hepatectomy and changes in the serum levels of HGF, IL-6 and soluble Fas in patients with viral hepatitis.
Gotohda N; Iwagaki H; Ozaki M; Kinoshita T; Konishi M; Nakagohri T; Takahashi S; Saito S; Yagi T; Tanaka N
Hepatogastroenterology; 2008; 55(85):1400-3. PubMed ID: 18795698
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor levels in liver and blood, and post-operative liver cell proliferation in patients with benign and malignant liver tumors after partial hepatectomy.
Dłuzniewska J; Zolich D; Polański J; Zajac L; Sitkiewicz D; Łukomska B
Med Sci Monit; 2002 Oct; 8(10):CR690-6. PubMed ID: 12388921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
